Leslie L. Iversen

Leslie L. Iversen

Fundador en Panos Therapeutics Ltd. .

86 años
Health Technology
Commercial Services
Consumer Services

Perfil

Leslie L.
Iversen
is the founder of Panos Therapeutics Ltd.
He currently holds the position of Director at Goalcrave Ltd.
since 1997 and is also an Associate Member at the National Academy of Sciences.
Previously, he served as the Independent Chairman at ACADIA Pharmaceuticals, Inc. from 1998 to 2016.
He has also held positions as the Director-Neurochemical Pharmacology Unit at The Medical Research Council, Vice President-Neuroscience Research at Merck Research Laboratories Massachusetts LLC, and Professor-Pharmacology at King's College London.
Dr. Iversen completed his undergraduate and doctorate degrees at the University of Cambridge.

Cargos activos de Leslie L. Iversen

EmpresasCargoInicio
Corporate Officer/Principal -
Panos Therapeutics Ltd. Fundador 20/07/2009
Director/Miembro de la Junta 01/10/1997
Todos los cargos activos de Leslie L. Iversen

Antiguos cargos conocidos de Leslie L. Iversen.

EmpresasCargoFin
ACADIA PHARMACEUTICALS INC. Presidente 10/06/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
King's College London Corporate Officer/Principal -
Ver el detalle de la experiencia de Leslie L. Iversen.

Formación de Leslie L. Iversen.

University of Cambridge Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Leslie L. Iversen.

Relaciones

100 +

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
ACADIA PHARMACEUTICALS INC.

Health Technology

Empresas privadas5

Commercial Services

Commercial Services

Health Technology

Panos Therapeutics Ltd.

Finance

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Leslie L. Iversen
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA